Hope in Advanced Myelofibrosis Trial | Philadelphia News

Hope is on the horizon for advanced myelofibrosis patients as scientists at Temple University’s Fox Chase Cancer Center test a powerful new combo therapy using two FDA-approved drugs. Designed not to cure, but to dramatically ease debilitating symptoms when all else fails, the treatment targets the root cause of blood cell overproduction. One patient, Demetria Mears, who battled the disease for over a decade, reports feeling “a thousand percent better” after joining the trial — a stunning turnaround from years of crushing fatigue and despair. Doctors are tracking symptom relief closely, and Mears’ inspiring recovery offers a beacon of progress in managing this aggressive blood cancer. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/9cb2fce5ad531cc1